2’,3’-protected nucleotides as building blocks for enzymatic de novo RNA synthesis

Marcel Hollenstein,Fabienne Levi-Acobas,Maëva Pichon,Camélia Kitoun

DOI: https://doi.org/10.26434/chemrxiv-2023-7m13d

2023-12-26

Abstract:Besides being a key player in numerous, fundamental biological process, RNA also represents a versatile platform for the creation of therapeutic agents and efficient vaccines. The production of RNA oligonucleotides, especially those decorated with chemical modifications, cannot meet the exponential demand. Due to the inherent limits of solid-phase synthesis and in vitro transcription, alternative, biocatalytic approaches are in dire need to facilitate the production of RNA oligonucleotides. Here, we present a first step towards the controlled enzymatic synthesis of RNA oligonucleotides. We have explored the possibility of a simple protection step of the vicinal cis-diol moiety to temporarily block ribonucleotides. We demonstrate that pyrimidine nucleotides protected with acetals, particularly 2',3'-O-isopropylidene, are well-tolerated by the template-independent RNA polymerase PUP (polyU polymerase) and highly efficient coupling reactions can be achieved within minutes – an important feature for the development of enzymatic de novo synthesis protocols. Even though purines are not equally well-tolerated, these findings clearly demonstrate the possibility of using cis-diol-protected ribonucleotides combined with template-independent polymerases for the stepwise construction of RNA oligonucleotides.

Chemistry

What problem does this paper attempt to address?

### The Problem the Paper Attempts to Solve

The paper aims to address the efficient synthesis of RNA oligonucleotides. Specifically:

1. **Background**:
- RNA, as an important component of therapeutics and highly effective vaccines, is in increasing demand.
- Existing solid-phase synthesis and in vitro transcription methods have limitations and cannot meet the growing demand.
- There is a need to develop new biocatalytic methods to facilitate the production of RNA oligonucleotides.

2. **Objectives**:
- Explore the use of nucleotide analogs modified with protecting groups as substrates for template-independent polymerases (such as PUP polymerase) to achieve controlled enzymatic synthesis of RNA.
- Specifically, investigate whether nucleotides protected with 2',3'-O-isopropylidene groups can be accepted by polymerases and achieve efficient single-step coupling reactions.

3. **Experimental Design**:
- Synthesized different types of nucleotides modified with protecting groups, including esters and acetals.
- Conducted primer extension experiments using PUP polymerase and PAP polymerase to evaluate the enzymatic synthesis compatibility of these modified nucleotides.

Through these studies, the paper aims to provide a new strategy for the controlled enzymatic synthesis of RNA oligonucleotides to meet the growing demand and improve synthesis efficiency.